AbbVie (ABBV) stock analysis and AI score
AbbVie has a Peakwise AI stock score of 76 out of 100, a strong profile, ranked 4 of 51 stocks as of Nov 6, 2026. The score describes price history and ratios. It is no advice.
Ranked 4 of 51 by AI score
End of day data as of Nov 6, 2026
AI Score Parts. Weights and values.
The AbbVie score is a weighted average of 6 parts. Each part ranks the stock from 0 to 100 against the other 50 stocks on the list, and 100 is the best rank.
Quality and valuation use company ratios such as net margin, debt and earnings yield.
- Momentum weight 30%92
- Trend weight 20%91
- Volatility weight 15%70
- Drawdown weight 15%81
- Quality weight 10%40
- Valuation weight 10%35
Price and Range. End of day Nov 6, 2026.
$291.31
Last close of ABBV in US dollars, as of Nov 6, 2026. Not a live quote.
- 1 month
- +6.9%
- 6 months
- +44.5%
- 1 year
- +34.4%
What This Score Means. Strong profile.
AbbVie scores 76. That is a strong profile, 4 points short of the top band, which starts at 80.
Momentum is the strongest part at 92, weighted 30%. It ranks the price change over 3, 6 and 12 months against the other stocks on the list. The price moved +44.5% over 6 months and +34.4% over 1 year. Valuation is the weakest at 35, weighted 10%. It looks at earnings yield and free cash flow yield.
As of Nov 6, 2026 the last close was $291.31. AbbVie sits 26 points above the middle of the list (a median of 50).
A high score does not mean the price will rise. It says the past looked strong next to the other stocks.
About AbbVie. Biopharmaceuticals.
AbbVie sells drugs for immune diseases, cancer and neurological conditions, and aesthetics products such as Botox. Humira was its flagship for years, and Skyrizi and Rinvoq followed as newer growth drugs. It split off from Abbott in 2013.
- Ticker
- ABBV
- Sector
- Health Care
- Industry
- Biopharmaceuticals
- Headquarters
- United States
Similar Stocks. Same sector first.
- Johnson & JohnsonJNJ · Health Care74Johnson & Johnson stock analysis and AI score
- MerckMRK · Health Care70Merck stock analysis and AI score
- Eli LillyLLY · Health Care64Eli Lilly stock analysis and AI score
- Thermo FisherTMO · Health Care63Thermo Fisher stock analysis and AI score
See every stock on the AI stock scores leaderboard, or sort and filter the same list with the AI stock finder.
Score FAQ. About AbbVie.
Research, not advice
Peakwise is a research tool. The AI score of AbbVie describes end of day price history and a few ratios compared with other large US stocks. It is not investment advice, a forecast or a recommendation to buy or sell. Read how it works on the AI stock score methodology page, or use the AI stock analysis tool for risks and a fair value range.
Go deeper. Past the score.
The score is the short version. The AI stock analysis of AbbVie adds financials, a fair value range, analyst views and risks.